Abstract
Standard treatment for glioblastoma is noncurative and only partially effective. Convection-enhanced delivery (CED) was developed as an alternative approach for effective loco-regional delivery of drugs via a small catheter inserted into the diseased brain. However, previous CED clinical trials revealed the need for improved catheters for controlled and satisfactory distribution of therapeutics. In this study, the arborizing catheter, consisting of six infusion ports, was compared to a reflux-preventing single-port catheter. Infusions of iohexol at a flow rate of 1 μL/min/microneedle were performed, using the arborizing catheter on one hemisphere and a single-port catheter on the contralateral hemisphere of excised pig brains. The volume dispersed (Vd) of the contrast agent was quantified for each catheter. Vd for the arborizing catheter was significantly higher than for the single-port catheter, 2235.8 ± 569.7 mm3 and 382.2 ± 243.0 mm3, respectively (n = 7). Minimal reflux was observed; however, high Vd values were achieved with the arborizing catheter. With simultaneous infusion using multiple ports of the arborizing catheter, high Vd was achieved at a low infusion rate. Thus, the arborizing catheter promises a highly desirable large volume of distribution of drugs delivered to the brain for the purpose of treating brain tumors.
Issue Section:
Research Papers
References
1.
Ostrom
,
Q. T.
,
Gittleman
,
H.
,
Xu
,
J.
,
Kromer
,
C.
,
Wolinsky
,
Y.
,
Kruchko
,
C.
, and
Barnholtz-Sloan
,
J. S.
, 2016
, “
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2009-2013
,” Neuro Oncol.
,
18
(suppl_5
), pp. v1
–v75
.10.1093/neuonc/now2072.
Debinski
,
W.
,
Priebe
,
W.
, and
Tatter
,
S. B.
, 2017
, Maximizing Local Access to Therapeutic Deliveries in Glioblastoma. Part I: Targeted Cytotoxic Therapy
,
S.
De Vleeschouwer Glioblastoma
, ed.,
Codon Publications
,
Brisbane, Australia
, pp. 341
–358
.3.
Nishikawa
,
R.
, 2010
, “
Standard Therapy for Glioblastoma—A Review of Where We Are
,” Neurol. Med. Chir. (Tokyo)
,
50
(9
), pp. 713
–719
.10.2176/nmc.50.7134.
Sanai
,
N.
, and
Berger
,
M. S.
, 2012
, “
Recent Surgical Management of Gliomas
,” Glioma: Immunotherapeutic Approaches
,
R.
Yamanaka
, ed.,
Springer
,
New York
, pp. 12
–25
.5.
Chan
,
M. D.
,
Tatter
,
S. B.
,
Lesser
,
G.
, and
Shaw
,
E. G.
, 2010
, “
Radiation Oncology in Brain Tumors: Current Approaches and Clinical Trials in Progress
,” Neuroimaging Clin. North Am.
,
20
(3
), pp. 401
–408
.10.1016/j.nic.2010.04.0056.
Lesser
,
G. J.
, and
Grossman
,
S.
, 1994
, “
The Chemotherapy of High-Grade Astrocytomas
,” Semin. Oncol.
,
21
(2
), pp. 220
–235
.https://pubmed.ncbi.nlm.nih.gov/8153666/7.
Stupp
,
R.
,
Mason
,
W. P.
,
van den Bent
,
M. J.
,
Weller
,
M.
,
Fisher
,
B.
,
Taphoorn
,
M. J.
,
Belanger
,
K.
,
Brandes
,
A. A.
,
Marosi
,
C.
,
Bogdahn
,
U.
,
Curschmann
,
J.
,
Janzer
,
R. C.
,
Ludwin
,
S. K.
,
Gorlia
,
T.
,
Allgeier
,
A.
,
Lacombe
,
D.
,
Cairncross
,
J. G.
,
Eisenhauer
,
E.
, and
Mirimanoff
,
R. O.
, 2005
, “
Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma
,” N. Engl. J. Med.
,
352
(10
), pp. 987
–996
.10.1056/NEJMoa0433308.
Chen
,
L.
,
Chaichana
,
K. L.
,
Kleinberg
,
L.
,
Ye
,
X.
,
Quinones-Hinojosa
,
A.
, and
Redmond
,
K.
, 2015
, “
Glioblastoma Recurrence Patterns Near Neural Stem Cell Regions
,” Radiother. Oncol.
,
116
(2
), pp. 294
–300
.10.1016/j.radonc.2015.07.0329.
Wallner
,
K. E.
,
Galicich
,
J. H.
,
Krol
,
G.
,
Arbit
,
E.
, and
Malkin
,
M. G.
, 1989
, “
Patterns of Failure Following Treatment of Glioblastoma Multiforme and Anaplastic Astrocytoma
,” Int. J. Radiat. Oncol. Biol. Phys.
,
16
(6
), pp. 1405
–1409
.10.1016/0360-3016(89)90941-310.
Groothuis
,
D. R.
, 2000
, “
The Blood-Brain and Blood-Tumor Barriers: A Review of Strategies for Increasing Drug Delivery
,” Neuro Oncol.
,
2
(1
), pp. 45
–59
.10.1093/neuonc/2.1.4511.
van Tellingen
,
O.
,
Yetkin-Arik
,
B.
,
de Gooijer
,
M. C.
,
Wesseling
,
P.
,
Wurdinger
,
T.
, and
de Vries
,
H. E.
, 2015
, “
Overcoming the Blood-Brain Tumor Barrier for Effective Glioblastoma Treatment
,” Drug Resist. Updat.
,
19
, pp. 1
–12
.10.1016/j.drup.2015.02.00212.
Bobo
,
R. H.
,
Laske
,
D. W.
,
Akbasak
,
A.
,
Morrison
,
P. F.
,
Dedrick
,
R. L.
, and
Oldfield
,
E. H.
, 1994
, “
Convection-Enhanced Delivery of Macromolecules in the Brain
,” Proc. Natl. Acad. Sci. U. S. A.
,
91
(6
), pp. 2076
–2080
.10.1073/pnas.91.6.207613.
Morrison
,
P. F.
,
Laske
,
D. W.
,
Bobo
,
H.
,
Oldfield
,
E. H.
, and
Dedrick
,
R. L.
, 1994
, “
High-Flow Microinfusion: Tissue Penetration and Pharmacodynamics
,” Am. J. Physiol.
,
266
(1
), pp. R292
–R305
.10.1152/ajpregu.1994.266.1.R29214.
Vandergrift
,
W. A.
,
Patel
,
S. J.
,
Nicholas
,
J. S.
, and
Varma
,
A. K.
, 2006
, “
Convection-Enhanced Delivery of Immunotoxins and Radioisotopes for Treatment of Malignant Gliomas
,” Neurosurg. Focus
,
20
(4
), p. E13
.10.3171/foc.2006.20.4.815.
Laske
,
D. W.
,
Youle
,
R. J.
, and
Oldfield
,
E. H.
, 1997
, “
Tumor Regression With Regional Distribution of the Targeted Toxin TF-CRM107 in Patients With Malignant Brain Tumors
,” Nat. Med.
,
3
(12
), pp. 1362
–1368
.10.1038/nm1297-136216.
Debinski
,
W.
,
Obiri
,
N. I.
,
Powers
,
S. K.
,
Pastan
,
I.
, and
Puri
,
R.
, 1995
, “
Human Glioma Cells Overexpress Receptors for Interleukin 13 and Are Extremely Sensitive to a Novel Chimeric Protein Composed of Interleukin 13 and Pseudomonas Exotoxin
,” Clin. Cancer Res.
,
1
, pp. 1253
–1258
.https://clincancerres.aacrjournals.org/content/1/11/1253.long17.
Debinski
,
W.
,
Gibo
,
D.
,
Hulet
,
S. W.
,
Connor
,
J. R.
, and
Gillespie
,
G. Y.
, 1999
, “
Receptor for Interleukin 13 is a Marker and Therapeutic Target for Human High-Grade Gliomas
,” Clin. Cancer Res.
,
5
, pp. 985
–990
.https://clincancerres.aacrjournals.org/content/5/5/98518.
Debinski
,
W.
,
Obiri
,
N. I.
,
Pastan
,
I.
, and
Puri
,
R. K.
, 1995
, “
A Novel Chimeric Protein Composed of Interleukin 13 and Pseudomonas Exotoxin is Highly Cytotoxic to Human Carcinoma Cells Expressing Receptors for Interleukin 13 and Interleukin 4
,” J. Biol. Chem.
,
270
(28
), pp. 16775
–16780
.10.1074/jbc.270.28.1677519.
Kunwar
,
S.
,
Prados
,
M. D.
,
Chang
,
S. M.
,
Berger
,
M. S.
,
Lang
,
F. F.
,
Piepmeier
,
J. M.
,
Sampson
,
J. H.
,
Ram
,
Z.
,
Gutin
,
P. H.
,
Gibbons
,
R. D.
,
Aldape
,
K. D.
,
Croteau
,
D. J.
,
Sherman
,
J. W.
,
Puri
,
R. K.
, and
Cintredekin Besudotox Intraparenchymal Study
,
G.
, 2007
, “
Direct Intracerebral Delivery of Cintredekin Besudotox (IL13-PE38QQR) in Recurrent Malignant Glioma: A Report by the Cintredekin Besudotox Intraparenchymal Study Group
,” J. Clin. Oncol.
,
25
(7
), pp. 837
–844
.10.1200/JCO.2006.08.111720.
Kunwar
,
S.
,
Chang
,
S.
,
Westphal
,
M.
,
Vogelbaum
,
M.
,
Sampson
,
J.
,
Barnett
,
G.
,
Shaffrey
,
M.
,
Ram
,
Z.
,
Piepmeier
,
J.
,
Prados
,
M.
,
Croteau
,
D.
,
Pedain
,
C.
,
Leland
,
P.
,
Husain
,
S. R.
,
Joshi
,
B. H.
,
Puri
,
R. K.
, and PRECISE Study Group,
2010
, “
Phase III Randomized Trial of CED of IL13-PE38QQR vs Gliadel Wafers for Recurrent Glioblastoma
,” Neuro Oncol.
,
12
(8
), pp. 871
–881
.10.1093/neuonc/nop05421.
Sampson
,
J. H.
,
Archer
,
G.
,
Pedain
,
C.
,
Wembacher-Schröder
,
E.
,
Westphal
,
M.
,
Kunwar
,
S.
,
Vogelbaum
,
M. A.
,
Coan
,
A.
,
Herndon
,
J. E.
,
Raghavan
,
R.
,
Brady
,
M. L.
,
Reardon
,
D. A.
,
Friedman
,
A. H.
,
Friedman
,
H. S.
,
Rodríguez-Ponce
,
M. I.
,
Chang
,
S. M.
,
Mittermeyer
,
S.
,
Croteau
,
D.
,
Puri
,
R. K.
, and PRECISE Trial Investigators, 2010
, “
Poor Drug Distribution as a Possible Explanation for the Results of the PRECISE Trial
,” J. Neurosurg.
,
113
(2
), pp. 301
–309
.10.3171/2009.11.JNS09105222.
Hochberg
,
F. H.
, and
Pruitt
,
A.
, 1980
, “
Assumptions in the Radiotherapy of Glioblastoma
,” Neurology
,
30
(9
), pp. 907
–911
.10.1212/WNL.30.9.90723.
Lonser
,
R. R.
,
Sarntinoranont
,
M.
,
Morrison
,
P. F.
, and
Oldfield
,
E. H.
, 2015
, “
Convection-Enhanced Delivery to the Central Nervous System
,” J. Neurosurg.
,
122
(3
), pp. 697
–706
.10.3171/2014.10.JNS1422924.
Schwartz
,
H. S.
, and
Spengler
,
D. M.
, 1997
, “
Needle Tract Recurrences After Closed Biopsy for Sarcoma: Three Cases and Review of the Literature
,” Ann. Surg. Oncol.
,
4
(3
), pp. 228
–236
.10.1007/BF0230661525.
Denton
,
K. J.
,
Cotton
,
D. W.
,
Nakielny
,
R. A.
, and
Goepel
,
J. R.
, 1990
, “
Secondary Tumour Deposits in Needle Biopsy Tracks: An Underestimated Risk?
,” J. Clin. Pathol.
,
43
(1
), pp. 83
–83
.10.1136/jcp.43.1.83-a26.
Debinski
,
W.
, and
Tatter
,
S. B.
, 2009
, “
Convection-Enhanced Delivery for the Treatment of Brain Tumors
,” Exp. Rev. Neurother.
,
9
(10
), pp. 1519
–1527
.10.1586/ern.09.9927.
Brady
,
M. L.
,
Raghavan
,
R.
,
Singh
,
D.
,
Anand
,
P. J.
,
Fleisher
,
A. S.
,
Mata
,
J.
,
Broaddus
,
W. C.
, and
Olbricht
,
W. L.
, 2014
, “
In Vivo Performance of a Microfabricated Catheter for Intraparenchymal Delivery
,” J. Neurosci. Meth.
,
229
, pp. 76
–83
.10.1016/j.jneumeth.2014.03.01628.
Gill
,
T.
,
Barua
,
N. U.
,
Woolley
,
M.
,
Bienemann
,
A. S.
,
Johnson
,
D. E.
,
Sullivan
,
S. O.
,
Murray
,
G.
,
Fennelly
,
C.
,
Lewis
,
O.
,
Irving
,
C.
,
Wyatt
,
M. J.
,
Moore
,
P.
, and
Gill
,
S. S.
, 2013
, “
In Vitro and In Vivo Testing of a Novel Recessed-Step Catheter for Reflux-Free Convection-Enhanced Drug Delivery to the Brain
,” J. Neurosci. Meth.
,
219
(1
), pp. 1
–9
.10.1016/j.jneumeth.2013.06.00829.
Krauze
,
M. T.
,
Saito
,
R.
,
Noble
,
C.
,
Tamas
,
M.
,
Bringas
,
J.
,
Park
,
J. W.
,
Berger
,
M. S.
, and
Bankiewicz
,
K.
, 2005
, “
Reflux-Free Cannula for Convection-Enhanced High-Speed Delivery of Therapeutic Agents
,” J. Neurosurg.
,
103
(5
), pp. 923
–929
.10.3171/jns.2005.103.5.092330.
Vazquez
,
L. C.
,
Hagel
,
E.
,
Willenberg
,
B. J.
,
Dai
,
W.
,
Casanova
,
F.
,
Batich
,
C. D.
, and
Sarntinoranont
,
M.
, 2012
, “
Polymer-Coated Cannulas for the Reduction of Backflow During Intraparenchymal Infusions
,” J. Mater. Sci. Mater. Med.
,
23
(8
), pp. 2037
–2046
.10.1007/s10856-012-4652-031.
Yin
,
D.
,
Forsayeth
,
J.
, and
Bankiewicz
,
K. S.
, 2010
, “
Optimized Cannula Design and Placement for Convection-Enhanced Delivery in Rat Striatum
,” J. Neurosci. Meth.
,
187
(1
), pp. 46
–51
.10.1016/j.jneumeth.2009.12.00832.
Vogelbaum
,
M. A.
,
Brewer
,
C.
,
Barnett
,
G. H.
,
Mohammadi
,
A. M.
,
Peereboom
,
D. M.
,
Ahluwalia
,
M. S.
, and
Gao
,
S.
, 2018
, “
First-in-Human Evaluation of the Cleveland Multiport Catheter for Convection-Enhanced Delivery of Topotecan in Recurrent High-Grade Glioma: Results of Pilot Trial 1
,” J. Neurosurg.
, pp. 1
–10
.10.3171/2017.10.JNS17184533.
Andriani
,
R. T.
, 2014
, Design and Validation of Medical Devices for Photothermally Augmented Treatments
,
Virginia Tech
,
Blacksburg, VA
.34.
Elenes
,
E. Y.
, and
Rylander
,
C. G.
, 2017
, Maximizing Local Access to Therapeutic Deliveries in Glioblastoma. Part II: Arborizing Catheter for Convection-Enhanced Delivery in Tissue Phantoms
,
S.
De Vleeschouwer Glioblastoma
, ed., Codon Publications,
Brisbane, Australia
.35.
Fiandaca
,
M. S.
,
Forsayeth
,
J. R.
,
Dickinson
,
P. J.
, and
Bankiewicz
,
K. S.
, 2008
, “
Image-Guided Convection-Enhanced Delivery Platform in the Treatment of Neurological Diseases
,” Neurotherapeutics
,
5
(1
), pp. 123
–127
.10.1016/j.nurt.2007.10.06436.
Vogelbaum
,
M. A.
, and
Aghi
,
M. K.
, 2015
, “
Convection-Enhanced Delivery for the Treatment of Glioblastoma
,” Neuro Oncol.
,
17
(Suppl. 2
), pp. ii3
–ii8
.10.1093/neuonc/nou35437.
Sampson
,
J. H.
,
Akabani
,
G.
,
Archer
,
G. E.
,
Bigner
,
D. D.
,
Berger
,
M. S.
,
Friedman
,
A. H.
,
Friedman
,
H. S.
,
Herndon Ii
,
J. E.
,
Kunwar
,
S.
,
Marcus
,
S.
,
McLendon
,
R. E.
,
Paolino
,
A.
,
Penne
,
K.
,
Provenzale
,
J.
,
Quinn
,
J.
,
Reardon
,
D. A.
,
Rich
,
J.
,
Stenzel
,
T.
,
Tourt-Uhlig
,
S.
,
Wikstrand
,
C.
,
Wong
,
T.
,
Williams
,
R.
,
Yuan
,
F.
,
Zalutsky
,
M. R.
, and
Pastan
,
I.
, 2003
, “
Progress Report of a Phase I Study of the Intracerebral Microinfusion of a Recombinant Chimeric Protein Composed of Transforming Growth Factor (TGF)-Α and a Mutated Form of the Pseudomonas Exotoxin Termed PE-38 (TP-38) for the Treatment of Malignant Brain Tumors
,” J. Neurooncol.
,
65
(1
), pp. 27
–35
.10.1023/A:102629031580938.
Chen
,
M. Y.
,
Lonser
,
R. R.
,
Morrison
,
P. F.
,
Governale
,
L. S.
, and
Oldfield
,
E. H.
, 1999
, “
Variables Affecting Convection-Enhanced Delivery to the Striatum: A Systematic Examination of Rate of Infusion, Cannula Size, Infusate Concentration, and Tissue–Cannula Sealing Time
,” J. Neurosurg.
,
90
(2
), pp. 315
–320
.10.3171/jns.1999.90.2.031539.
Rand
,
R. W.
,
Kreitman
,
R. J.
,
Patronas
,
N.
,
Varricchio
,
F.
,
Pastan
,
I.
, and
Puri
,
R. K.
, 2000
, “
Intratumoral Administration of Recombinant Circularly Permuted Interleukin-4-Pseudomonas Exotoxin in Patients With High-Grade Glioma
,” Clin. Cancer Res.
,
6
(6
), pp. 2157
–2165
.https://clincancerres.aacrjournals.org/content/6/6/215740.
Patel
,
S. J.
,
Shapiro
,
W. R.
,
Laske
,
D. W.
,
Jensen
,
R. L.
,
Asher
,
A. L.
,
Wessels
,
B. W.
,
Carpenter
,
S. P.
, and
Shan
,
J. S.
, 2005
, “
Safety and Feasibility of Convection-Enhanced Delivery of Cotara for the Treatment of Malignant Glioma: Initial Experience in 51 Patients
,” Neurosurgery
,
56
(6
), pp. 1243
–1253
.10.1227/01.NEU.0000159649.71890.3041.
Varenika
,
V.
,
Dickinson
,
P.
,
Bringas
,
J.
,
LeCouteur
,
R.
,
Higgins
,
R.
,
Park
,
J.
,
Fiandaca
,
M. S.
,
Berger
,
M.
,
Sampson
,
J.
, and
Bankiewicz
,
K.
, 2008
, “
Detection of Infusate Leakage in the Brain Using Real-Time Imaging of Convection-Enhanced Delivery
,” J. Neurosurg.
,
109
(5
), pp. 874
–880
.10.3171/JNS/2008/109/11/087442.
Polivka
,
J.
, Jr.
,
Polivka
,
J.
,
Holubec
,
L.
,
Kubikova
,
T.
,
Priban
,
V.
,
Hes
,
O.
,
Pivovarcikova
,
K.
, and
Treskova
,
I.
, 2017
, “
Advances in Experimental Targeted Therapy and Immunotherapy for Patients With Glioblastoma Multiforme
,” Anticancer Res.
,
37
(1
), pp. 21
–33
.10.21873/anticanres.1128543.
Touat
,
M.
,
Idbaih
,
A.
,
Sanson
,
M.
, and
Ligon
,
K. L.
, 2017
, “
Glioblastoma Targeted Therapy: Updated Approaches From Recent Biological Insights
,” Ann. Oncol.
,
28
(7
), pp. 1457
–1472
.10.1093/annonc/mdx10644.
Xu
,
Y. Y.
,
Gao
,
P.
,
Sun
,
Y.
, and
Duan
,
Y. R.
, 2015
, “
Development of Targeted Therapies in Treatment of Glioblastoma
,” Cancer Biol. Med.
,
12
(3
), pp. 223
–237
.10.7497/j.issn.2095-3941.2015.002045.
Morrison
,
P. F.
,
Chen
,
M. Y.
,
Chadwick
,
R. S.
,
Lonser
,
R. R.
, and
Oldfield
,
E. H.
, 1999
, “
Focal Delivery During Direct Infusion to Brain: Role of Flow Rate, Catheter Diameter, and Tissue Mechanics
,” Am. J. Physiol.
,
277
(4
), pp. R1218
–R1229
.10.1152/ajpregu.1999.277.4.R121846.
Hood
,
R. L.
,
Andriani
,
R. T.
,
Ecker
,
T. E.
,
Robertson
,
J. L.
, and
Rylander
,
C. G.
, 2015
, “
Characterizing Thermal Augmentation of Convection-Enhanced Drug Delivery With the Fiberoptic Microneedle Device
,” Engineering
,
1
(3
), pp. 344
–350
.10.15302/J-ENG-201507747.
Hood
,
R. L.
,
Andriani
,
R. T.
, Jr.
,
Emch
,
S.
,
Robertson
,
J. L.
,
Rylander
,
C. G.
, and
Rossmeisl
,
J. H.
, Jr.
, 2013
, “
Fiberoptic Microneedle Device Facilitates Volumetric Infusate Dispersion During Convection-Enhanced Delivery in the Brain
,” Lasers Surg. Med.
,
45
(7
), pp. 418
–426
.10.1002/lsm.22156Copyright © 2021 by ASME
You do not currently have access to this content.
